Equities Analysts Offer Predictions for UNH Q4 Earnings

UnitedHealth Group Incorporated (NYSE:UNH) – Equities researchers at Zacks Research dropped their Q4 2027 earnings estimates for UnitedHealth Group in a note issued to investors on Tuesday, September 15th. Zacks Research analyst Team now anticipates that the healthcare conglomerate will earn $4.06 per share for the quarter, down from their previous estimate of $4.07. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for UnitedHealth Group’s current full-year earnings is $19.82 per share.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. During the same period in the previous year, the company earned $4.08 EPS. The firm’s revenue for the quarter was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS.

Other equities research analysts have also issued reports about the company. Oppenheimer raised their price target on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a research note on Friday, July 17th. Wells Fargo & Company increased their target price on UnitedHealth Group from $397.00 to $485.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Erste Group Bank lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, August 27th. HSBC raised their price target on shares of UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a research note on Monday, July 6th. Finally, Robert W. Baird upgraded shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and upped their target price for the stock from $287.00 to $453.00 in a research note on Thursday, July 16th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $456.56.

UnitedHealth Group Stock Down 2.0%

Shares of NYSE:UNH opened at $375.95 on Wednesday. The firm has a market capitalization of $337.46 billion, a PE ratio of 24.19, a price-to-earnings-growth ratio of 1.44 and a beta of 0.61. The business has a 50 day simple moving average of $406.84 and a two-hundred day simple moving average of $369.73. UnitedHealth Group has a 1 year low of $255.96 and a 1 year high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. U S Wealth Group LLC. raised its holdings in UnitedHealth Group by 11.8% during the second quarter. U S Wealth Group LLC. now owns 8,901 shares of the healthcare conglomerate’s stock worth $3,700,000 after purchasing an additional 937 shares in the last quarter. Bouchey Financial Group Ltd. grew its position in shares of UnitedHealth Group by 23.8% in the 2nd quarter. Bouchey Financial Group Ltd. now owns 1,242 shares of the healthcare conglomerate’s stock valued at $516,000 after buying an additional 239 shares during the last quarter. Core Capital Management & Research inc. purchased a new stake in UnitedHealth Group in the second quarter valued at $49,000. Sequoia Financial Advisors LLC boosted its stake in UnitedHealth Group by 5.1% in the second quarter. Sequoia Financial Advisors LLC now owns 56,842 shares of the healthcare conglomerate’s stock valued at $23,625,000 after acquiring an additional 2,741 shares in the last quarter. Finally, Van Hulzen Asset Management LLC increased its position in shares of UnitedHealth Group by 20.0% during the second quarter. Van Hulzen Asset Management LLC now owns 11,817 shares of the healthcare conglomerate’s stock worth $4,911,000 after purchasing an additional 1,972 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s payout ratio is currently 59.72%.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth’s raised fiscal 2026 earnings outlook, recent revenue and EPS beats, and stable 86.7% medical loss ratio are supporting the bullish case. Analysts have reportedly increased estimates, while the company’s free-cash-flow yield and valuation may attract long-term investors. UnitedHealth: Lagging, But An Upbeat 2026 Outlook Helps Clear The Path
• Positive Sentiment: UnitedHealth’s use of artificial intelligence across its insurance operations is being highlighted as a potential long-term efficiency and growth driver, reinforcing the company’s competitive positioning. How UnitedHealth Leads the AI Revolution in the Insurance Industry
• Neutral Sentiment: UnitedHealth will report third-quarter 2026 results before the market opens on October 13. The date provides a future catalyst, but does not change current earnings expectations. UnitedHealth Group Announces Earnings Release Date
• Neutral Sentiment: UBS expects UnitedHealth’s earnings-growth outlook to remain broadly intact, although investors continue to focus on Medicare Advantage trends ahead of the next results. UnitedHealth Earnings Growth Outlook Unlikely to Change, UBS Says
• Negative Sentiment: UnitedHealth is selling an interest in underperforming WellMed clinics in Florida to TPG, citing the need for local operating expertise rather than cash. The transaction underscores cost pressures, restrictive Medicare Advantage payments, and the operational reset at Optum Health—issues that are weighing on near-term sentiment. UnitedHealth Partners with TPG to Strengthen Underperforming Florida Clinics
• Negative Sentiment: The September 14 ex-dividend date may create short-term technical pressure, though shareholders of record remain eligible for the $2.32-per-share cash dividend payable September 22. UnitedHealth Group Dividend Analysis

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.